Alcon AG Logo

Alcon AG

ALC | SW

Overview

Corporate Details

ISIN(s):
CH0432492467
LEI:
549300LDT5AP8S0NBM78
Country:
Switzerland
Address:
RUE LOUIS-D'AFFRY 6, 1701 FRIBOURG
Sector:
Manufacturing
Industry:
Manufacture of medical and dental instruments and supplies

Description

Alcon AG is a global leader in eye care, specializing in the research, development, manufacturing, and distribution of medical devices and pharmaceutical products. The company operates through two primary segments: Surgical and Vision Care. The Surgical division provides a comprehensive portfolio of ophthalmic surgical products, including equipment and technologies for cataract, vitreoretinal, and refractive surgeries. The Vision Care segment offers a wide range of contact lenses and ocular health products, such as lens care solutions. Serving healthcare professionals and consumers worldwide, Alcon aims to enhance sight and improve lives through its innovative product offerings.

Social Media

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Alcon AG. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2000-08-30 15:20
Annual Report
Alco - Algodeira Comercial e Industrial, SGPS, S.A. - Exercício de 1999.
English 1.9 MB

Automate Your Workflow. Get a real-time feed of all Alcon AG filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Alcon AG via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2025-05-15 N/A Non-Executive member Buy None 219,000.00 CHF
2025-05-06 N/A Non-Executive member Buy None 167,500.00 CHF
2025-05-06 N/A Non-Executive member Buy None 150,000.00 CHF
2025-05-06 N/A Non-Executive member Buy None 147,500.00 CHF
2025-03-03 N/A Executive member Sell None 1,058,041.00 CHF
2025-02-28 N/A Executive member Sell None 1,659,244.26 CHF
2025-02-27 N/A Executive member Sell None 741,943.41 CHF
2024-09-12 N/A Executive member Sell None 9,595,590.28 CHF
2024-09-12 N/A Executive member Sell None 852,639.92 CHF
2024-09-09 N/A Executive member Sell None 378,434.32 CHF

Peer Companies

Company Country Ticker View
Theradiag Logo
Develops IVD tests for biotherapy monitoring in autoimmune diseases and oncology.
France ALTER
TISSUE REGENIX GROUP PLC Logo
Develops regenerative biological products for orthopaedic and dental markets.
United Kingdom TRX
Developing disruptive spinal fixation devices for the vertebral surgery market.
United Kingdom N/A
Ulisse Biomed Logo
Provides a portable platform for rapid point-of-need genetic analysis and diagnostics.
Italy UBM
Viromed Medical Logo
Develops cold plasma tech for infection control, wound care, and air disinfection for healthcare.
Germany VMED
Vitrolife Logo
Global provider of medical devices and genetic testing services for the IVF treatment journey.
Sweden VITR
Xvivo Perfusion Logo
Develops ex-vivo machine perfusion systems to improve organ viability for transplantation.
Sweden XVIVO
Ypsomed Holding AG Logo
Develops injection systems for self-medication, partnering with pharma and biotech firms.
Switzerland YPSN